Drug & intervention
bismuth subsalicylate Oral Suspension [Kaopectate Reformulated Aug 2006]
RxCUI 642345
What this record represents
SBDF · RxNormThis is an RxNorm SBDF drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.
What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.
Related drug records
RxNorm name matchesThese are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.
Kaopectate Reformulated Aug 2006BN · CureCurrent ID 36999
bismuth subsalicylate 262 MG [Kaopectate Reformulated Aug 2006]SBDC · CureCurrent ID 36777
bismuth subsalicylate 35 MG/ML [Kaopectate Reformulated Aug 2006]SBDC · CureCurrent ID 48509
bismuth subsalicylate 17.5 MG/ML [Kaopectate Reformulated Aug 2006]SBDC · CureCurrent ID 36774
bismuth subsalicylate Oral Tablet [Kaopectate Reformulated Aug 2006]SBDF · CureCurrent ID 36778
bismuth subsalicylate Chewable Tablet [Kaopectate Reformulated Aug 2006]SBDF · CureCurrent ID 71926
bismuth subsalicylate 262 MG Oral Tablet [Kaopectate Reformulated Aug 2006]SBD · CureCurrent ID 36779
bismuth subsalicylate 262 MG Chewable Tablet [Kaopectate Reformulated Aug 2006]SBD · CureCurrent ID 71927
bismuth subsalicylate 35 MG/ML Oral Suspension [Kaopectate Reformulated Aug 2006]SBD · CureCurrent ID 48510
bismuth subsalicylate 17.5 MG/ML Oral Suspension [Kaopectate Reformulated Aug 2006]SBD · CureCurrent ID 36776
Molecular structure
Active ingredient: bismuth subsalicylateAdvertisement
Conditions being studied
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.